ロード中...
Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
SIMPLE SUMMARY: Among primary brain tumours, glioblastoma is the most aggressive. As early relapses are unavoidable despite standard-of-care treatment, the cannabinoids delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) alone or in combination have been suggested as a combined treatment strate...
保存先:
| 出版年: | Cells |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7914500/ https://ncbi.nlm.nih.gov/pubmed/33562819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10020340 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|